360 related articles for article (PubMed ID: 16838338)
1. EBV negative Richter's syndrome from a coexistent clone after salvage treatment with alemtuzumab in a CLL patient.
Janssens A; Berth M; De Paepe P; Verhasselt B; Van Roy N; Noens L; Philippé J; Offner F
Am J Hematol; 2006 Sep; 81(9):706-12. PubMed ID: 16838338
[TBL] [Abstract][Full Text] [Related]
2. Hodgkin's disease variant of Richter's syndrome in chronic lymphocytic leukaemia patients previously treated with fludarabine.
Fong D; Kaiser A; Spizzo G; Gastl G; Tzankov A
Br J Haematol; 2005 Apr; 129(2):199-205. PubMed ID: 15813847
[TBL] [Abstract][Full Text] [Related]
3. Richter's transformation of chronic lymphocytic leukemia with Hodgkin's-like cells is associated with Epstein-Barr virus infection.
Rubin D; Hudnall SD; Aisenberg A; Jacobson JO; Harris NL
Mod Pathol; 1994 Jan; 7(1):91-8. PubMed ID: 8159658
[TBL] [Abstract][Full Text] [Related]
4. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
[TBL] [Abstract][Full Text] [Related]
5. Hodgkin's disease variant of Richter's syndrome clonally related to chronic lymphocytic leukemia arises in ZAP-70 negative mutated CLL.
Tzankov A; Fong D
Med Hypotheses; 2006; 66(3):577-9. PubMed ID: 16223567
[TBL] [Abstract][Full Text] [Related]
6. Distinct clonal origin in two cases of Hodgkin's lymphoma variant of Richter's syndrome associated With EBV infection.
de Leval L; Vivario M; De Prijck B; Zhou Y; Boniver J; Harris NL; Isaacson P; Du MQ
Am J Surg Pathol; 2004 May; 28(5):679-86. PubMed ID: 15105659
[TBL] [Abstract][Full Text] [Related]
7. Fatal adenoviral and enteroviral infections and an Epstein-Barr virus positive large B-cell lymphoma after alemtuzumab treatment in a patient with refractory Sézary syndrome.
Roch N; Salameire D; Gressin R; Morand P; Epaulard O; Pavese P; Brion JP; Stahl JP
Scand J Infect Dis; 2008; 40(4):343-6. PubMed ID: 17934981
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus infection in Richter's transformation.
Ansell SM; Li CY; Lloyd RV; Phyliky RL
Am J Hematol; 1999 Feb; 60(2):99-104. PubMed ID: 9929100
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous Richter's syndrome, prognosis, and clinical, histological and immunohistological patterns: report of four cases and review of the literature.
Duong T; Grange F; Auffret N; Aractingi S; Bodemer C; Brousse N; Hermine O; Fraitag S
Dermatology; 2010; 220(3):226-33. PubMed ID: 20145381
[TBL] [Abstract][Full Text] [Related]
10. Epstein-barr virus-positive diffuse large B-cell lymphoma during therapy with alemtuzumab for T-cell prolymphocytic leukemia.
Sohani AR; Ferry JA; Chang PS; Abramson JS
J Clin Oncol; 2010 Feb; 28(5):e69-72. PubMed ID: 19917859
[No Abstract] [Full Text] [Related]
11. Richter's transformation in chronic lymphocytic leukemia.
Tsimberidou AM; Keating MJ
Semin Oncol; 2006 Apr; 33(2):250-6. PubMed ID: 16616072
[TBL] [Abstract][Full Text] [Related]
12. Antigen receptors and somatic hypermutation in B-cell chronic lymphocytic leukemia with Richter's transformation.
Smit LA; van Maldegem F; Langerak AW; van der Schoot CE; de Wit MJ; Bea S; Campo E; Bende RJ; van Noesel CJ
Haematologica; 2006 Jul; 91(7):903-11. PubMed ID: 16818277
[TBL] [Abstract][Full Text] [Related]
13. Alemtuzumab for B-cell chronic lymphocytic leukemia.
Robak T
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1033-51. PubMed ID: 18588450
[TBL] [Abstract][Full Text] [Related]
14. Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?
Hale G; Slavin S; Goldman JM; Mackinnon S; Giralt S; Waldmann H
Bone Marrow Transplant; 2002 Dec; 30(12):797-804. PubMed ID: 12476271
[TBL] [Abstract][Full Text] [Related]
15. Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival.
Moreton P; Kennedy B; Lucas G; Leach M; Rassam SM; Haynes A; Tighe J; Oscier D; Fegan C; Rawstron A; Hillmen P
J Clin Oncol; 2005 May; 23(13):2971-9. PubMed ID: 15738539
[TBL] [Abstract][Full Text] [Related]
16. Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemia.
O'Brien SM; Kantarjian HM; Thomas DA; Cortes J; Giles FJ; Wierda WG; Koller CA; Ferrajoli A; Browning M; Lerner S; Albitar M; Keating MJ
Cancer; 2003 Dec; 98(12):2657-63. PubMed ID: 14669286
[TBL] [Abstract][Full Text] [Related]
17. Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia.
Montillo M; Tedeschi A; Miqueleiz S; Veronese S; Cairoli R; Intropido L; Ricci F; Colosimo A; Scarpati B; Montagna M; Nichelatti M; Regazzi M; Morra E
J Clin Oncol; 2006 May; 24(15):2337-42. PubMed ID: 16618945
[TBL] [Abstract][Full Text] [Related]
18. Hodgkin's lymphoma variant of Richter's syndrome.
Vasilj A; Kojić-Katović S; Maricević I; Zokvić E; Kelcec IB; Tomas D; Curić-Jurić S
Coll Antropol; 2010 Mar; 34(1):295-9. PubMed ID: 20437646
[TBL] [Abstract][Full Text] [Related]
19. Different clonal origin of B-cell populations of chronic lymphocytic leukemia and large-cell lymphoma in Richter's syndrome.
Matolcsy A; Casali P; Knowles DM
Ann N Y Acad Sci; 1995 Sep; 764():496-503. PubMed ID: 7486574
[TBL] [Abstract][Full Text] [Related]
20. Relationship between the mutational status of VH genes and pathogenesis of diffuse large B-cell lymphoma in Richter's syndrome.
Timár B; Fülöp Z; Csernus B; Angster C; Bognár A; Szepesi A; Kopper L; Matolcsy A
Leukemia; 2004 Feb; 18(2):326-30. PubMed ID: 14671632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
